The Data-Driven Path to Biosimilar Success | Data Dive with PurpleLab This podcast was created in collaboration with the Pharmacy Podcast Network. In this episode, we are exploring a fascinating topic: how real-world data is reshaping the landscape of biosimilars. Dr. Russell Robbins, Chief Medical Information Officer and Dr. Diane Faraone, Senior Director in Pharmacy…

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

Data-Driven Diversity: PurpleLab’s Approach to Inclusive Clinical Trials This podcast was created in collaboration with the Pharmacy Podcast Network. In this episode, we delve into the critical topic of Diversity, Equity, and Inclusion (DEI) in clinical trials. Todd introduces PurpleLab and welcomes Dr. Russell Robbins, Chief Medical Information Management for Life Sciences. Together, they explore…

PurpleLab® is driven by a singular goal – to provide healthcare organizations with robust and accessible real-world data (RWD) and real-world evidence (RWE) to solve conventional and emerging challenges, including tackling medication adherence. According to the FDA[1], real-world evidence (RWE) is defined as “the clinical evidence that looks at the usage and potential benefits or…

The fact that healthcare organizations need to improve care outcomes is undeniably undisputed. To succeed, health plan leaders need to acknowledge that medical care is estimated to account for only 10% to 20% of the modifiable contributors to healthy outcomes for a population. The other 80% to 90% emanates from social determinants of health (SDOH),…

This blog is part four in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Medical affairs is a department within pharmaceutical companies that focuses on communicating scientific and clinical information to healthcare providers. Pharmaceutical medical affairs teams are responsible for activities that bridge the gap between the development…

Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…

Pharma brand managers have a data problem: namely, they have access to so much of it that it can inundate their decision-making processes. We outline the best ways of streamlining the volume of information and separating the proverbial wheat from the chaff. This is a video recording of a speaking session produced in partnership with…

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 diabetes mellitus (T2DM) and obesity.[1] This class of medications assists in lowering blood sugar levels and promotes weight loss. In addition to treating diabetics, these medications are also used to treat obesity in diabetics as well as non-diabetics.   GLP-1 drugs…